73 results
8-K
EX-1.1
ivfy5qrktpi 48l
26 Jan 24
Other Events
4:12pm
424B5
s0z3tf 1yx0ny4tsd0hg
26 Jan 24
Prospectus supplement for primary offering
4:08pm
424B5
gaagfa3kr
24 Jan 24
Prospectus supplement for primary offering
9:20pm
8-K
EX-99.3
3pm8gi
24 Jan 24
Results of Operations and Financial Condition
5:10pm
8-K
EX-99.2
i3bqpv1
24 Jan 24
Results of Operations and Financial Condition
5:10pm
8-K
EX-99.1
nsagymsutjek7a gau
24 Jan 24
Results of Operations and Financial Condition
5:10pm
8-K
EX-99.1
qyq64ye
14 Nov 23
Index to Unaudited Condensed Financial Statements
5:15pm
8-K
i9qi h5df
27 Oct 23
Departure of Directors or Certain Officers
5:17pm
8-K
EX-10.1
naxgfm1wdjjezevaw4b
27 Oct 23
Departure of Directors or Certain Officers
5:17pm
8-K
EX-10.10
8a9y45i
19 Oct 23
Tourmaline Bio Announces Closing of Merger with Talaris Therapeutics and Concurrent Private Placement of $75 Million
9:11pm
8-K
EX-10.7
dwiae4k
19 Oct 23
Tourmaline Bio Announces Closing of Merger with Talaris Therapeutics and Concurrent Private Placement of $75 Million
9:11pm
8-K
EX-10.9
qgz358
19 Oct 23
Tourmaline Bio Announces Closing of Merger with Talaris Therapeutics and Concurrent Private Placement of $75 Million
9:11pm
8-K
EX-10.8
dc02 qwo6ht6iwmbwnbz
19 Oct 23
Tourmaline Bio Announces Closing of Merger with Talaris Therapeutics and Concurrent Private Placement of $75 Million
9:11pm
424B3
zx0q5iiqe1p9srawjoiy
15 Sep 23
Prospectus supplement
6:31am